Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
MNOV Medicinova Inc
- Stocks
- Healthcare
- NASDAQ: MNOV
Price (delayed)
$1.43
Market cap
$70.14M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.23
Enterprise value
$33.75M
MediciNova, Inc. is a publicly-traded biopharmaceutical company founded upon developing novel, small-molecule therapeutics for the treatment of diseases with unmet medical needs with a primary commercial focus on the U.S.
Highlights
The debt has contracted by 13% YoY and by 2% from the previous quarter
The quick ratio has grown by 26% from the previous quarter but it has contracted by 9% YoY
Medicinova's gross profit has shrunk by 100% YoY
The company's revenue has shrunk by 100% YoY
Key stats
What are the main financial stats of MNOV
Market
Valuations
Earnings
Shares outstanding
49.05M
Market cap
$70.14M
Enterprise value
$33.75M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.4
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$12.76M
Net income
-$11.16M
EBIT
-$11.15M
EBITDA
-$10.96M
Free cash flow
-$10.56M
Per share
Balance sheet
Liquidity
EPS
-$0.23
EPS diluted
-$0.23
Free cash flow per share
-$0.22
Book value per share
$1.02
Revenue per share
$0
TBVPS
$0.87
Total assets
$52.43M
Total liabilities
$2.5M
Debt
$189,860
Equity
$49.93M
Working capital
$35.55M
Debt to equity
0
Current ratio
17.66
Quick ratio
17.14
Net debt/EBITDA
3.32
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-19.7%
Return on equity
-20.8%
Return on invested capital
-288.4%
Return on capital employed
-22.2%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
MNOV stock price
How has the Medicinova stock price performed over time
Intraday
1.42%
1 week
0.7%
1 month
-5.3%
1 year
2.14%
YTD
-31.9%
QTD
-2.05%
Financial performance
How have Medicinova's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$12.76M
Net income
-$11.16M
Gross margin
N/A
Net margin
N/A
Medicinova's gross profit has shrunk by 100% YoY
The company's revenue has shrunk by 100% YoY
MNOV's net income is down by 33% YoY
The operating income is down by 26% year-on-year
Price vs fundamentals
How does MNOV's price correlate with its fundamentals
Growth
What is Medicinova's growth rate over time
Valuation
What is Medicinova stock price valuation
P/E
N/A
P/B
1.4
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
MNOV's EPS is down by 35% year-on-year
The P/B is 26% lower than the 5-year quarterly average of 1.9 and 13% lower than the last 4 quarters average of 1.6
The equity has declined by 17% year-on-year and by 4.9% since the previous quarter
The company's revenue has shrunk by 100% YoY
Efficiency
How efficient is Medicinova business performance
Medicinova's return on equity has shrunk by 56% YoY and by 6% QoQ
The ROA has shrunk by 56% YoY and by 6% QoQ
MNOV's ROIC is down by 25% YoY
Dividends
What is MNOV's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for MNOV.
Financial health
How did Medicinova financials performed over time
MNOV's current ratio is up by 27% since the previous quarter but it is down by 7% year-on-year
The quick ratio has grown by 26% from the previous quarter but it has contracted by 9% YoY
The debt is 100% less than the equity
The equity has declined by 17% year-on-year and by 4.9% since the previous quarter
The debt has contracted by 13% YoY and by 2% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.